Practice Test GeeksPEBC - Pharmacy Examining Board of Canada Practice Test
← All PEBC Flashcard Decks

Certification Process Flashcards

6 cards from real PEBC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 Certification Process flashcards as text

  1. A pharmacist trained in the Philippines completed the PEBC Evaluating Examination (EE) but failed the Qualifying Examination Part I (MCQ) twice. Under PEBC's current policy, what is the consequence and the soonest they may attempt Part I again?

    Answer: They must wait 12 months after the second failure and may attempt Part I a third and final time before being barred.

    PEBC policy allows candidates a maximum of three attempts at each Qualifying Examination component. After the second failure, a mandatory 12-month waiting period is imposed before the third and final attempt. Failing a third time results in permanent disqualification from that component, not an automatic requirement to retake the EE.

  2. A Canadian-trained pharmacy graduate applies to register in a province that uses the PEBC Qualifying Examination. She holds an ACPE-accredited Pharm.D. obtained at a U.S. school while on a student visa. PEBC classifies her credential as:

    Answer: A foreign credential requiring full completion of the Evaluating Examination before she may sit the Qualifying Examination.

    PEBC distinguishes between Canadian pharmacy programs accredited by CCAPP and U.S. programs accredited by ACPE. A Pharm.D. from a U.S. ACPE-accredited school is treated as a foreign (internationally educated) credential by PEBC. The graduate must therefore pass the Evaluating Examination before proceeding to the Qualifying Examination, regardless of the degree level or ACPE accreditation status.

  3. During the Qualifying Examination Part II (OSCE), a candidate is found to have smuggled in a prohibited reference card. The examining proctor confiscates the card mid-station. Under PEBC's examination integrity policy, the most likely immediate outcome is:

    Answer: The candidate completes the remaining OSCE stations, and PEBC's Examination Committee reviews the incident before deciding on any sanction.

    PEBC's irregularity policy allows the candidate to complete the examination while the incident is documented and reported. The Examination Committee then reviews the evidence before determining the consequence, which may range from voiding specific stations to full disqualification. Immediate dismissal mid-OSCE is not standard PEBC procedure; due process requires a committee review prior to imposing sanctions.

  4. A pharmacist certified under the PEBC process wishes to obtain a Statement of Standing to support registration in a new Canadian province. Which of the following accurately describes the scope of information PEBC provides in such a statement?

    Answer: Pass/fail status for examinations passed, the number of attempts for each component, and whether the certificate remains in good standing.

    A PEBC Statement of Standing confirms which examinations were passed, discloses the number of attempts taken (relevant to provincial regulators assessing candidate history), and states whether the pharmacist's PEBC certification is currently in good standing. PEBC does not release numerical scores or itemized domain breakdowns to third-party regulators; those details are reserved for the candidate's own score report.

  5. An internationally educated pharmacist (IEP) passes the PEBC Evaluating Examination in 2021. Due to personal circumstances, she does not apply for the Qualifying Examination until 2027. PEBC's validity window for EE results is:

    Answer: Five years from the date of the EE result letter; she would need to retake the EE before sitting the Qualifying Examination.

    PEBC imposes a five-year validity period on Evaluating Examination results. A candidate who passed in 2021 must proceed to (and pass) the Qualifying Examination by 2026. Applying in 2027 means the EE result has expired, requiring the candidate to retake and pass the Evaluating Examination before being eligible for the Qualifying Examination again. No CE attestation extends the window.

  6. PEBC introduced the Pharmacy Examining Board of Canada Drug Therapeutic Index (PEBC DTI) as a permitted reference during the Qualifying Examination Part I. Which statement most precisely describes its role in the examination context?

    Answer: It defines the scope of drug knowledge candidates are expected to master; the actual examination is closed-book with no reference access.

    The PEBC DTI is a blueprint document that delineates the drug and therapeutic knowledge base within scope for the Qualifying Examination Part I. The MCQ examination itself is administered under closed-book conditions — no reference materials, including the DTI, may be consulted during the sitting. Candidates use the DTI during preparation to understand what drug knowledge will be assessed, not as a reference during the exam.